STOCK TITAN

[8-K] Zimmer Biomet Holdings, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Barclays Bank PLC is issuing $452,000 of unsecured, unsubordinated Buffered Supertrack SM Notes linked to the price return of the Russell 2000 Index (RTY). The notes are part of the bank’s Global Medium-Term Notes, Series A and will be offered in $1,000 denominations on 30 Jun 2025, maturing 30 Dec 2027.

  • Payout profile – If the index is flat or up at maturity, investors receive principal plus 2× upside, capped at a 31.35 % maximum return ($1,313.50 per $1,000 note).
  • Downside buffer – First 10 % decline is fully protected. Below the 90 % Buffer Value (1,922.57), losses are linear: every additional 1 % drop erodes 1 % of principal, up to a 90 % loss.
  • Key parameters: Initial Value 2,136.185; Upside Leverage 2.0; Buffer 10 %; CUSIP 06746BX71; Estimated value on pricing date $965.70 (≈3.4 % below issue price).
  • Costs & liquidity: 2.75 % selling commission; no exchange listing; Barclays Capital intends, but is not obliged, to make a secondary market.
  • Credit & regulatory risk: Payments depend on Barclays’ creditworthiness and are subject to the U.K. Bail-in Power, meaning principal could be written down or converted to equity during resolution.
  • Tax & withholding: Issuer views the notes as prepaid forward contracts; U.S. tax treatment uncertain; Section 871(m) not expected to apply (delta ≠ 1).

The structure targets investors who can forgo coupons, accept a capped return, and tolerate meaningful equity and issuer risk in exchange for a modest downside buffer and enhanced—though limited—upside participation.

Barclays Bank PLC emette $452.000 di Buffered Supertrack SM Notes non garantite e non subordinate collegate al rendimento del prezzo dell'indice Russell 2000 (RTY). Le note fanno parte della Serie A dei Global Medium-Term Notes della banca e saranno offerte in tagli da $1.000 il 30 giugno 2025, con scadenza il 30 dicembre 2027.

  • Profilo di rendimento – Se l'indice è stabile o in crescita alla scadenza, gli investitori ricevono il capitale più un rendimento doppio rispetto all’aumento, con un rendimento massimo del 31,35% ($1.313,50 per ogni nota da $1.000).
  • Protezione al ribasso – Il primo calo del 10% è completamente protetto. Sotto il valore buffer del 90% (1.922,57), le perdite sono lineari: ogni ulteriore calo dell’1% riduce l’1% del capitale, fino a una perdita massima del 90%.
  • Parametri chiave: Valore iniziale 2.136,185; Leva al rialzo 2,0; Buffer 10%; CUSIP 06746BX71; Valore stimato alla data di emissione $965,70 (circa 3,4% sotto il prezzo di emissione).
  • Costi e liquidità: Commissione di vendita 2,75%; nessuna quotazione in borsa; Barclays Capital intende, ma non è obbligata, a creare un mercato secondario.
  • Rischio di credito e regolamentare: I pagamenti dipendono dalla solidità creditizia di Barclays e sono soggetti al potere di bail-in del Regno Unito, il che significa che il capitale potrebbe essere ridotto o convertito in azioni in caso di risoluzione.
  • Fiscale e ritenute: L’emittente considera le note come contratti forward prepagati; trattamento fiscale USA incerto; non si prevede l’applicazione della Sezione 871(m) (delta ≠ 1).

La struttura è pensata per investitori disposti a rinunciare ai coupon, accettare un rendimento massimo e tollerare rischi significativi legati all’equity e all’emittente, in cambio di una protezione parziale dal ribasso e una partecipazione limitata ma migliorata al rialzo.

Barclays Bank PLC emite $452,000 en Buffered Supertrack SM Notes no garantizadas y no subordinadas vinculadas al rendimiento del precio del índice Russell 2000 (RTY). Las notas forman parte de la Serie A de los Global Medium-Term Notes del banco y se ofrecerán en denominaciones de $1,000 el 30 de junio de 2025, con vencimiento el 30 de diciembre de 2027.

  • Perfil de pago – Si el índice está igual o sube al vencimiento, los inversores reciben el principal más el doble de la subida, con un rendimiento máximo del 31,35% ($1,313.50 por cada nota de $1,000).
  • Protección a la baja – La primera caída del 10% está completamente protegida. Por debajo del valor buffer del 90% (1,922.57), las pérdidas son lineales: cada caída adicional del 1% reduce el 1% del principal, hasta una pérdida máxima del 90%.
  • Parámetros clave: Valor inicial 2,136.185; Apalancamiento al alza 2.0; Buffer 10%; CUSIP 06746BX71; Valor estimado en la fecha de emisión $965.70 (aproximadamente 3.4% por debajo del precio de emisión).
  • Costos y liquidez: Comisión de venta 2.75%; sin cotización en bolsa; Barclays Capital tiene la intención, pero no está obligado, de crear un mercado secundario.
  • Riesgo crediticio y regulatorio: Los pagos dependen de la solvencia de Barclays y están sujetos al poder de rescate del Reino Unido, lo que significa que el principal podría reducirse o convertirse en acciones durante una resolución.
  • Fiscalidad y retenciones: El emisor considera las notas como contratos a plazo prepagados; tratamiento fiscal en EE.UU. incierto; no se espera aplicación de la Sección 871(m) (delta ≠ 1).

La estructura está dirigida a inversores que pueden renunciar a cupones, aceptar un rendimiento máximo y tolerar riesgos significativos de acciones y del emisor a cambio de una protección moderada a la baja y una participación mejorada, aunque limitada, al alza.

Barclays Bank PLC는 러셀 2000 지수(RTY)의 가격 수익률에 연동된 $452,000 규모의 무담보 비후순위 Buffered Supertrack SM Notes를 발행합니다. 이 노트들은 은행의 글로벌 중기채권 시리즈 A에 포함되며, 2025년 6월 30일에 $1,000 단위로 발행되어 2027년 12월 30일에 만기됩니다.

  • 지급 프로필 – 만기 시 지수가 변동 없거나 상승하면 투자자는 원금과 상승분의 2배를 받으며, 최대 31.35% 수익($1,000 노트당 $1,313.50)로 한정됩니다.
  • 하락 보호 – 최초 10% 하락은 전액 보호됩니다. 90% 버퍼 값(1,922.57) 이하로 내려가면 손실은 선형적으로 발생하며, 추가 1% 하락 시 원금 1%가 감소하여 최대 90% 손실까지 가능합니다.
  • 주요 파라미터: 초기 값 2,136.185; 상승 레버리지 2.0; 버퍼 10%; CUSIP 06746BX71; 발행일 추정 가치 $965.70 (발행가 대비 약 3.4% 낮음).
  • 비용 및 유동성: 판매 수수료 2.75%; 거래소 상장 없음; Barclays Capital은 2차 시장 조성을 계획하나 의무는 아님.
  • 신용 및 규제 위험: 지급은 Barclays 신용도에 의존하며, 영국의 베일인 권한 적용 대상이므로 원금이 감액되거나 주식으로 전환될 수 있습니다.
  • 세금 및 원천징수: 발행자는 노트를 선불 선도계약으로 간주; 미국 세금 처리는 불확실; 섹션 871(m) 적용 예상되지 않음 (델타 ≠ 1).

이 구조는 쿠폰을 포기할 수 있고, 수익 상한을 받아들이며, 상당한 주식 및 발행자 위험을 감수하는 투자자에게 적합하며, 이에 대한 대가로 완만한 하락 보호와 제한적이지만 향상된 상승 참여를 제공합니다.

Barclays Bank PLC émet 452 000 $ de Buffered Supertrack SM Notes non garanties et non subordonnées liées au rendement en prix de l’indice Russell 2000 (RTY). Ces notes font partie de la série A des Global Medium-Term Notes de la banque et seront proposées en coupures de 1 000 $ le 30 juin 2025, avec échéance au 30 décembre 2027.

  • Profil de paiement – Si l’indice est stable ou en hausse à l’échéance, les investisseurs perçoivent le capital plus deux fois la hausse, plafonnée à un rendement maximum de 31,35 % (1 313,50 $ par note de 1 000 $).
  • Protection à la baisse – La première baisse de 10 % est entièrement protégée. En dessous de la valeur buffer de 90 % (1 922,57), les pertes sont linéaires : chaque baisse supplémentaire de 1 % réduit 1 % du capital, jusqu’à une perte maximale de 90 %.
  • Paramètres clés : Valeur initiale 2 136,185 ; effet de levier à la hausse 2,0 ; buffer 10 % ; CUSIP 06746BX71 ; valeur estimée à la date de tarification 965,70 $ (environ 3,4 % en dessous du prix d’émission).
  • Coûts et liquidité : commission de vente de 2,75 % ; pas de cotation en bourse ; Barclays Capital prévoit, sans obligation, de créer un marché secondaire.
  • Risques de crédit et réglementaires : Les paiements dépendent de la solvabilité de Barclays et sont soumis au pouvoir de bail-in britannique, ce qui signifie que le capital pourrait être réduit ou converti en actions en cas de résolution.
  • Fiscalité et retenues : L’émetteur considère les notes comme des contrats à terme prépayés ; traitement fiscal américain incertain ; la section 871(m) ne devrait pas s’appliquer (delta ≠ 1).

Cette structure cible les investisseurs capables de renoncer aux coupons, d’accepter un rendement plafonné et de tolérer des risques significatifs liés aux actions et à l’émetteur, en échange d’une protection modérée à la baisse et d’une participation accrue, bien que limitée, à la hausse.

Barclays Bank PLC gibt unbesicherte, nicht nachrangige Buffered Supertrack SM Notes im Wert von 452.000 $ aus, die an die Kursrendite des Russell 2000 Index (RTY) gekoppelt sind. Die Notes sind Teil der Global Medium-Term Notes, Serie A der Bank und werden am 30. Juni 2025 in Stückelungen von 1.000 $ angeboten, mit Fälligkeit am 30. Dezember 2027.

  • Auszahlungsprofil – Ist der Index bei Fälligkeit unverändert oder gestiegen, erhalten Anleger das Kapital plus das 2-fache des Anstiegs, begrenzt auf eine maximale Rendite von 31,35 % (1.313,50 $ pro 1.000 $ Note).
  • Abwärtspuffer – Die ersten 10 % Kursrückgang sind vollständig geschützt. Unterhalb des 90 % Buffer-Werts (1.922,57) sind Verluste linear: Jeder weitere 1 % Rückgang mindert 1 % des Kapitals, bis zu einem maximalen Verlust von 90 %.
  • Wichtige Parameter: Anfangswert 2.136,185; Upside Hebel 2,0; Puffer 10 %; CUSIP 06746BX71; Geschätzter Wert am Preisfeststellungstag 965,70 $ (ca. 3,4 % unter dem Ausgabepreis).
  • Kosten & Liquidität: Verkaufsprovision 2,75 %; keine Börsennotierung; Barclays Capital beabsichtigt, aber ist nicht verpflichtet, einen Sekundärmarkt bereitzustellen.
  • Kredit- & regulatorisches Risiko: Zahlungen hängen von der Kreditwürdigkeit von Barclays ab und unterliegen der britischen Bail-in-Regelung, was bedeutet, dass das Kapital im Rahmen einer Abwicklung abgeschrieben oder in Eigenkapital umgewandelt werden kann.
  • Steuern & Quellensteuer: Emittent betrachtet die Notes als vorab bezahlte Terminkontrakte; US-Steuerbehandlung unklar; Abschnitt 871(m) wird nicht erwartet (Delta ≠ 1).

Die Struktur richtet sich an Anleger, die auf Kupons verzichten können, eine begrenzte Rendite akzeptieren und wesentliche Aktien- sowie Emittentenrisiken tolerieren, um im Gegenzug einen moderaten Abwärtsschutz und eine verbesserte, wenn auch begrenzte Aufwärtsbeteiligung zu erhalten.

Positive
  • 10 % downside buffer absorbs moderate equity declines before principal is at risk.
  • 2× upside participation up to a 31.35 % cap enables enhanced returns versus direct RTY exposure within a defined range.
  • Short 2.5-year tenor reduces duration exposure relative to longer-dated structured notes.
Negative
  • Maximum return is capped at 31.35 %, limiting gains if the Russell 2000 rallies strongly.
  • Up to 90 % principal loss once the index falls more than 10 %, exposing investors to significant downside.
  • Estimated value ($965.70) is materially below issue price, indicating ~3.4 % embedded costs at launch.
  • Issuer credit and U.K. bail-in risk mean repayment depends on Barclays’ solvency and regulatory actions.
  • No exchange listing and small deal size could result in poor secondary-market liquidity.

Insights

TL;DR – Leverage to 31 % upside with 10 % buffer, but high issuer and liquidity risk makes outcome highly path-dependent.

The notes offer a clear risk-reward trade-off: double the small-cap upside until 15.675 % index appreciation, after which returns are capped. The 10 % buffer is typical for two-to-three-year retail structures and will only absorb mild equity drawdowns; beyond that, losses accelerate 1-for-1. Investors effectively exchange dividend rights and uncapped growth for leveraged but limited participation plus serious tail risk. Pricing is expensive: the bank’s own model value ($965.70) sits 34.3 points below issue price, largely covering the 2.75 % commission, hedging costs and issuer margin. Credit exposure to Barclays and potential bail-in further differentiate this from traditional debt.

Because secondary liquidity is dealer-driven, exit pricing will incorporate both bid/ask spreads and issuer credit spreads, typically leaving early sellers at a material discount. The small $452k deal size suggests limited aftermarket depth. Overall, the note may suit fee-based accounts seeking defined-outcome exposure to U.S. small caps over 30 months, provided they are comfortable with credit, liquidity, and buffer limitations.

TL;DR – Niche, short-dated defined-outcome note best viewed as tactical satellite, not core holding.

Strategically, the instrument behaves like a short-put/long-call spread on the Russell 2000 layered over a Barclays credit note. At issuance, the embedded option premium (difference between $1,000 price and $965.70 model value) approximates 3.5 %, implying investors overpay relative to delta-hedged replication. The 31.35 % cap translates to an annualized 11.8 % max yield—attractive if the investor’s bullish view materializes inside two years, but structurally inferior to simply holding RTY ETF beyond the cap. In stressed equity markets, the 90 % potential loss combined with Barclays’ bail-in risk could materially impair portfolios. Thus, allocation should be limited and paired with diversified credit exposure.

Barclays Bank PLC emette $452.000 di Buffered Supertrack SM Notes non garantite e non subordinate collegate al rendimento del prezzo dell'indice Russell 2000 (RTY). Le note fanno parte della Serie A dei Global Medium-Term Notes della banca e saranno offerte in tagli da $1.000 il 30 giugno 2025, con scadenza il 30 dicembre 2027.

  • Profilo di rendimento – Se l'indice è stabile o in crescita alla scadenza, gli investitori ricevono il capitale più un rendimento doppio rispetto all’aumento, con un rendimento massimo del 31,35% ($1.313,50 per ogni nota da $1.000).
  • Protezione al ribasso – Il primo calo del 10% è completamente protetto. Sotto il valore buffer del 90% (1.922,57), le perdite sono lineari: ogni ulteriore calo dell’1% riduce l’1% del capitale, fino a una perdita massima del 90%.
  • Parametri chiave: Valore iniziale 2.136,185; Leva al rialzo 2,0; Buffer 10%; CUSIP 06746BX71; Valore stimato alla data di emissione $965,70 (circa 3,4% sotto il prezzo di emissione).
  • Costi e liquidità: Commissione di vendita 2,75%; nessuna quotazione in borsa; Barclays Capital intende, ma non è obbligata, a creare un mercato secondario.
  • Rischio di credito e regolamentare: I pagamenti dipendono dalla solidità creditizia di Barclays e sono soggetti al potere di bail-in del Regno Unito, il che significa che il capitale potrebbe essere ridotto o convertito in azioni in caso di risoluzione.
  • Fiscale e ritenute: L’emittente considera le note come contratti forward prepagati; trattamento fiscale USA incerto; non si prevede l’applicazione della Sezione 871(m) (delta ≠ 1).

La struttura è pensata per investitori disposti a rinunciare ai coupon, accettare un rendimento massimo e tollerare rischi significativi legati all’equity e all’emittente, in cambio di una protezione parziale dal ribasso e una partecipazione limitata ma migliorata al rialzo.

Barclays Bank PLC emite $452,000 en Buffered Supertrack SM Notes no garantizadas y no subordinadas vinculadas al rendimiento del precio del índice Russell 2000 (RTY). Las notas forman parte de la Serie A de los Global Medium-Term Notes del banco y se ofrecerán en denominaciones de $1,000 el 30 de junio de 2025, con vencimiento el 30 de diciembre de 2027.

  • Perfil de pago – Si el índice está igual o sube al vencimiento, los inversores reciben el principal más el doble de la subida, con un rendimiento máximo del 31,35% ($1,313.50 por cada nota de $1,000).
  • Protección a la baja – La primera caída del 10% está completamente protegida. Por debajo del valor buffer del 90% (1,922.57), las pérdidas son lineales: cada caída adicional del 1% reduce el 1% del principal, hasta una pérdida máxima del 90%.
  • Parámetros clave: Valor inicial 2,136.185; Apalancamiento al alza 2.0; Buffer 10%; CUSIP 06746BX71; Valor estimado en la fecha de emisión $965.70 (aproximadamente 3.4% por debajo del precio de emisión).
  • Costos y liquidez: Comisión de venta 2.75%; sin cotización en bolsa; Barclays Capital tiene la intención, pero no está obligado, de crear un mercado secundario.
  • Riesgo crediticio y regulatorio: Los pagos dependen de la solvencia de Barclays y están sujetos al poder de rescate del Reino Unido, lo que significa que el principal podría reducirse o convertirse en acciones durante una resolución.
  • Fiscalidad y retenciones: El emisor considera las notas como contratos a plazo prepagados; tratamiento fiscal en EE.UU. incierto; no se espera aplicación de la Sección 871(m) (delta ≠ 1).

La estructura está dirigida a inversores que pueden renunciar a cupones, aceptar un rendimiento máximo y tolerar riesgos significativos de acciones y del emisor a cambio de una protección moderada a la baja y una participación mejorada, aunque limitada, al alza.

Barclays Bank PLC는 러셀 2000 지수(RTY)의 가격 수익률에 연동된 $452,000 규모의 무담보 비후순위 Buffered Supertrack SM Notes를 발행합니다. 이 노트들은 은행의 글로벌 중기채권 시리즈 A에 포함되며, 2025년 6월 30일에 $1,000 단위로 발행되어 2027년 12월 30일에 만기됩니다.

  • 지급 프로필 – 만기 시 지수가 변동 없거나 상승하면 투자자는 원금과 상승분의 2배를 받으며, 최대 31.35% 수익($1,000 노트당 $1,313.50)로 한정됩니다.
  • 하락 보호 – 최초 10% 하락은 전액 보호됩니다. 90% 버퍼 값(1,922.57) 이하로 내려가면 손실은 선형적으로 발생하며, 추가 1% 하락 시 원금 1%가 감소하여 최대 90% 손실까지 가능합니다.
  • 주요 파라미터: 초기 값 2,136.185; 상승 레버리지 2.0; 버퍼 10%; CUSIP 06746BX71; 발행일 추정 가치 $965.70 (발행가 대비 약 3.4% 낮음).
  • 비용 및 유동성: 판매 수수료 2.75%; 거래소 상장 없음; Barclays Capital은 2차 시장 조성을 계획하나 의무는 아님.
  • 신용 및 규제 위험: 지급은 Barclays 신용도에 의존하며, 영국의 베일인 권한 적용 대상이므로 원금이 감액되거나 주식으로 전환될 수 있습니다.
  • 세금 및 원천징수: 발행자는 노트를 선불 선도계약으로 간주; 미국 세금 처리는 불확실; 섹션 871(m) 적용 예상되지 않음 (델타 ≠ 1).

이 구조는 쿠폰을 포기할 수 있고, 수익 상한을 받아들이며, 상당한 주식 및 발행자 위험을 감수하는 투자자에게 적합하며, 이에 대한 대가로 완만한 하락 보호와 제한적이지만 향상된 상승 참여를 제공합니다.

Barclays Bank PLC émet 452 000 $ de Buffered Supertrack SM Notes non garanties et non subordonnées liées au rendement en prix de l’indice Russell 2000 (RTY). Ces notes font partie de la série A des Global Medium-Term Notes de la banque et seront proposées en coupures de 1 000 $ le 30 juin 2025, avec échéance au 30 décembre 2027.

  • Profil de paiement – Si l’indice est stable ou en hausse à l’échéance, les investisseurs perçoivent le capital plus deux fois la hausse, plafonnée à un rendement maximum de 31,35 % (1 313,50 $ par note de 1 000 $).
  • Protection à la baisse – La première baisse de 10 % est entièrement protégée. En dessous de la valeur buffer de 90 % (1 922,57), les pertes sont linéaires : chaque baisse supplémentaire de 1 % réduit 1 % du capital, jusqu’à une perte maximale de 90 %.
  • Paramètres clés : Valeur initiale 2 136,185 ; effet de levier à la hausse 2,0 ; buffer 10 % ; CUSIP 06746BX71 ; valeur estimée à la date de tarification 965,70 $ (environ 3,4 % en dessous du prix d’émission).
  • Coûts et liquidité : commission de vente de 2,75 % ; pas de cotation en bourse ; Barclays Capital prévoit, sans obligation, de créer un marché secondaire.
  • Risques de crédit et réglementaires : Les paiements dépendent de la solvabilité de Barclays et sont soumis au pouvoir de bail-in britannique, ce qui signifie que le capital pourrait être réduit ou converti en actions en cas de résolution.
  • Fiscalité et retenues : L’émetteur considère les notes comme des contrats à terme prépayés ; traitement fiscal américain incertain ; la section 871(m) ne devrait pas s’appliquer (delta ≠ 1).

Cette structure cible les investisseurs capables de renoncer aux coupons, d’accepter un rendement plafonné et de tolérer des risques significatifs liés aux actions et à l’émetteur, en échange d’une protection modérée à la baisse et d’une participation accrue, bien que limitée, à la hausse.

Barclays Bank PLC gibt unbesicherte, nicht nachrangige Buffered Supertrack SM Notes im Wert von 452.000 $ aus, die an die Kursrendite des Russell 2000 Index (RTY) gekoppelt sind. Die Notes sind Teil der Global Medium-Term Notes, Serie A der Bank und werden am 30. Juni 2025 in Stückelungen von 1.000 $ angeboten, mit Fälligkeit am 30. Dezember 2027.

  • Auszahlungsprofil – Ist der Index bei Fälligkeit unverändert oder gestiegen, erhalten Anleger das Kapital plus das 2-fache des Anstiegs, begrenzt auf eine maximale Rendite von 31,35 % (1.313,50 $ pro 1.000 $ Note).
  • Abwärtspuffer – Die ersten 10 % Kursrückgang sind vollständig geschützt. Unterhalb des 90 % Buffer-Werts (1.922,57) sind Verluste linear: Jeder weitere 1 % Rückgang mindert 1 % des Kapitals, bis zu einem maximalen Verlust von 90 %.
  • Wichtige Parameter: Anfangswert 2.136,185; Upside Hebel 2,0; Puffer 10 %; CUSIP 06746BX71; Geschätzter Wert am Preisfeststellungstag 965,70 $ (ca. 3,4 % unter dem Ausgabepreis).
  • Kosten & Liquidität: Verkaufsprovision 2,75 %; keine Börsennotierung; Barclays Capital beabsichtigt, aber ist nicht verpflichtet, einen Sekundärmarkt bereitzustellen.
  • Kredit- & regulatorisches Risiko: Zahlungen hängen von der Kreditwürdigkeit von Barclays ab und unterliegen der britischen Bail-in-Regelung, was bedeutet, dass das Kapital im Rahmen einer Abwicklung abgeschrieben oder in Eigenkapital umgewandelt werden kann.
  • Steuern & Quellensteuer: Emittent betrachtet die Notes als vorab bezahlte Terminkontrakte; US-Steuerbehandlung unklar; Abschnitt 871(m) wird nicht erwartet (Delta ≠ 1).

Die Struktur richtet sich an Anleger, die auf Kupons verzichten können, eine begrenzte Rendite akzeptieren und wesentliche Aktien- sowie Emittentenrisiken tolerieren, um im Gegenzug einen moderaten Abwärtsschutz und eine verbesserte, wenn auch begrenzte Aufwärtsbeteiligung zu erhalten.

false 0001136869 0001136869 2025-06-27 2025-06-27 0001136869 us-gaap:CommonStockMember 2025-06-27 2025-06-27 0001136869 zbh:M2.425NotesDue2026Member 2025-06-27 2025-06-27 0001136869 zbh:M1.164NotesDue2027Member 2025-06-27 2025-06-27 0001136869 zbh:M3.518NotesDue2032Member 2025-06-27 2025-06-27
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 27, 2025

 

 

ZIMMER BIOMET HOLDINGS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-16407   13-4151777

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

345 East Main Street  
Warsaw, Indiana   46580
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (574) 373-3333

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value   ZBH   New York Stock Exchange
2.425% Notes due 2026   ZBH 26   New York Stock Exchange
1.164% Notes due 2027   ZBH 27   New York Stock Exchange
3.518% Notes due 2032   ZBH 32   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into a Material Definitive Agreement.

On June 27, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) entered into a new five-year revolving credit agreement and a new 364-day revolving credit agreement, as described below.

The Five-Year Revolving Credit Agreement, dated as of June 27, 2025, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Five-Year Credit Agreement”), is a five-year unsecured revolving facility of $1.5 billion (the “Five-Year Revolving Facility”). The Five-Year Credit Agreement will mature on June 27, 2030, with two one-year extensions exercisable at the Company’s discretion and subject to required lender consent. The Five-Year Credit Agreement also includes an uncommitted incremental feature allowing the Company to request an increase of the facility by an aggregate amount of up to $500.0 million. Borrowings under the Five-Year Revolving Facility will be used for general corporate purposes.

Borrowings under the Five-Year Credit Agreement will bear interest at floating rates, based upon either an adjusted Term secured overnight financing rate (“SOFR”) for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to the Company’s senior unsecured long-term debt credit rating. The Company will pay a facility fee on the aggregate amount of the Five-Year Revolving Facility at a rate determined by reference to the Company’s senior unsecured long-term debt credit rating.

The Five-Year Credit Agreement contains customary affirmative and negative covenants and events of default for unsecured financing arrangements, including, among other things, limitations on consolidations, mergers, and sales of assets. The Five-Year Credit Agreement also requires that the Company maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 in connection with a qualified material acquisition and certain other restrictions).

On June 27, 2025, the Company borrowed $50.0 million under the Five-Year Credit Agreement, replacing a portion of the borrowings outstanding as of such date under the prior five-year credit agreement, which was terminated in connection with the entry into the Five-Year Credit Agreement, as described further below in Item 1.02.

The 364-Day Revolving Credit Agreement, dated as of June 27, 2025, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “364-Day Credit Agreement”), is an unsecured revolving credit facility in the principal amount of $1.0 billion (the “364-Day Revolving Facility”). The 364-Day Credit Agreement will mature on June 26, 2026, and borrowings under the 364-Day Revolving Facility will be used for general corporate purposes.

Borrowings under the 364-Day Credit Agreement will bear interest at floating rates based upon either an adjusted Term SOFR for the applicable interest period or an alternate base rate, in each case, plus an applicable margin determined by reference to the Company’s senior unsecured long-term debt credit rating. The Company will pay a facility fee on the aggregate amount of the 364-Day Revolving Facility at a rate determined by reference to its senior unsecured long-term debt credit rating.

The 364-Day Credit Agreement contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement, including, among other things, limitations on consolidations, mergers and sales of assets. The 364-Day Credit Agreement also requires that the Company maintain a consolidated indebtedness to consolidated EBITDA ratio of no greater than 4.5 to 1.0 as of the last day of any period of four consecutive fiscal quarters (with such ratio subject to increase to 5.0 to 1.0 in connection with a qualified material acquisition and certain other restrictions).

The foregoing descriptions of the Five-Year Credit Agreement and the 364-Day Credit Agreement are qualified in their entirety by reference to the full text of the Five-Year Credit Agreement and the 364-Day Credit Agreement, which are filed as Exhibit 10.1 and Exhibit 10.2 hereto, respectively, and are incorporated herein by reference.


In the ordinary course of business, certain of the lenders under the Five-Year Credit Agreement and/or the 364-Day Credit Agreement and their affiliates have provided, and may in the future provide, investment banking, commercial banking, cash management, foreign exchange or other financial services to the Company and its affiliates for which they have received, and may in the future receive, compensation.

 

Item 1.02

Termination of a Material Definitive Agreement.

In connection with the entry into the Five-Year Credit Agreement and the 364-Day Credit Agreement, on June 27, 2025, the Five-Year Revolving Credit Agreement, dated as of June 28, 2024, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “2024 Five-Year Credit Agreement”), and the 364-Day Revolving Credit Agreement, dated as of June 28, 2024, among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “2024 364-Day Credit Agreement”) were terminated and are of no further force or effect (except with respect to any obligations and provisions that survive the termination thereof).

There was no principal balance outstanding under the 2024 364-Day Credit Agreement at the time it was terminated. There were borrowings in the aggregate amount (inclusive of principal, interest and fees) of approximately $50.7 million outstanding under the 2024 Five-Year Credit Agreement at the time it was terminated. Of such borrowings, $50.0 million was repaid through borrowings on June 27, 2025 in the same amounts and on the same terms under the Five-Year Credit Agreement, and approximately $0.7 million was repaid by the Company with cash on hand. Further, all existing letters of credit issued under the 2024 Five-Year Credit Agreement were transitioned to, and now constitute outstanding letters of credit under, the Five-Year Credit Agreement.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure required by this Item is included in Item 1.01, which is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.
  

Description

10.1    Five-Year Revolving Credit Agreement, dated as of June 27, 2025, among Zimmer Biomet Holdings, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent
10.2    364-Day Revolving Credit Agreement, dated as of June 27, 2025, among Zimmer Biomet Holdings, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 30, 2025

 

ZIMMER BIOMET HOLDINGS, INC.
By:  

/s/ Chad F. Phipps

Name:   Chad F. Phipps
Title:  

Senior Vice President, General Counsel

and Secretary

FAQ

What is the upside cap for Barclays VXZ Buffered Supertrack Notes?

The notes cap total return at 31.35 %, delivering a maximum payment of $1,313.50 per $1,000 note.

How much protection does the 10 % buffer provide on the Russell 2000 Index?

If the index ends within 10 % below its initial level, investors receive full principal; below that, losses are 1-for-1.

What are the key dates for these 424B2 notes?

Initial Valuation 25 Jun 2025; Issue 30 Jun 2025; Final Valuation 27 Dec 2027; Maturity 30 Dec 2027.

How do selling commissions impact investor proceeds?

Barclays Capital earns a 2.75 % commission, contributing to the gap between the $1,000 price and $965.70 estimated value.

Are the notes listed or easily tradable before maturity?

No. The notes will not be listed; any secondary trading depends solely on dealer willingness, with potentially wide spreads.

How does the U.K. Bail-in Power affect investors?

Regulators can write down or convert the notes if Barclays is in resolution, which could wipe out principal irrespective of index performance.
Zimmer Biomet

NYSE:ZBH

ZBH Rankings

ZBH Latest News

ZBH Latest SEC Filings

ZBH Stock Data

18.15B
197.53M
0.2%
93.68%
3.54%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WARSAW